Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of ‘real-world’ vaccination outcomes from Israel
View ORCID ProfilePaul R Hunter, View ORCID ProfileJulii Brainard
doi: https://doi.org/10.1101/2021.02.01.21250957
Paul R Hunter
1The Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK
Julii Brainard
1The Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted February 03, 2021.
Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of ‘real-world’ vaccination outcomes from Israel
Paul R Hunter, Julii Brainard
medRxiv 2021.02.01.21250957; doi: https://doi.org/10.1101/2021.02.01.21250957
Subject Area
Subject Areas
- Addiction Medicine (343)
- Allergy and Immunology (666)
- Anesthesia (180)
- Cardiovascular Medicine (2629)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12181)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4070)
- Geriatric Medicine (387)
- Health Economics (678)
- Health Informatics (2627)
- Health Policy (998)
- Hematology (361)
- HIV/AIDS (845)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (431)
- Neurology (3839)
- Nursing (209)
- Nutrition (571)
- Oncology (2011)
- Ophthalmology (582)
- Orthopedics (239)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (74)
- Pathology (471)
- Pediatrics (1109)
- Primary Care Research (448)
- Public and Global Health (6504)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (401)
- Sports Medicine (341)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)